This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2017 Apr 11;317(14):1477-1478.

doi: 10.1001/jama.2017.2562.

Zoledronic Acid Dosing Interval for Metastatic Cancer

Marcello Tucci¹, Consuelo Buttigliero¹, Massimo Di Maio²

Affiliations

Affiliations

¹ University of Turin, San Luigi Gonzaga Hospital, Orbassano (Turin), Italy.
² University of Turin, Ordine Mauriziano Hospital, Turin, Italy.

PMID: 28399243
DOI: 10.1001/jama.2017.2562

Comment

Zoledronic Acid Dosing Interval for Metastatic Cancer

Marcello Tucci et al. JAMA. 2017.

. 2017 Apr 11;317(14):1477-1478.

doi: 10.1001/jama.2017.2562.

Authors

Marcello Tucci¹, Consuelo Buttigliero¹, Massimo Di Maio²

Affiliations

¹ University of Turin, San Luigi Gonzaga Hospital, Orbassano (Turin), Italy.
² University of Turin, Ordine Mauriziano Hospital, Turin, Italy.

PMID: 28399243
DOI: 10.1001/jama.2017.2562

No abstract available

PubMed Disclaimer

Comment in

Zoledronic Acid Dosing Interval for Metastatic Cancer-Reply.
Himelstein AL, Loprinzi CL, Shapiro CL. Himelstein AL, et al. JAMA. 2017 Apr 11;317(14):1478. doi: 10.1001/jama.2017.2566. JAMA. 2017. PMID: 28399247 No abstract available.

Comment on

Effect of Longer-Interval vs Standard Dosing of Zoledronic Acid on Skeletal Events in Patients With Bone Metastases: A Randomized Clinical Trial.
Himelstein AL, Foster JC, Khatcheressian JL, Roberts JD, Seisler DK, Novotny PJ, Qin R, Go RS, Grubbs SS, O'Connor T, Velasco MR Jr, Weckstein D, O'Mara A, Loprinzi CL, Shapiro CL. Himelstein AL, et al. JAMA. 2017 Jan 3;317(1):48-58. doi: 10.1001/jama.2016.19425. JAMA. 2017. PMID: 28030702 Free PMC article. Clinical Trial.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions

LinkOut - more resources

Full Text Sources
- Ovid Technologies, Inc.
- Silverchair Information Systems
Other Literature Sources
- scite Smart Citations